SGLT2 inhibitors failed to improve survival in patients hospitalised with COVID-19 Dr. Kamal Kant Kohli31 Aug 2023 10:00 AM ISTUSA: Findings from a recent study failed to support the use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients hospitalized with...
ESC 2023 Update: Study suggests against switching to newer anticoagulants in frail elderly patients with atrial fibrillation Dr. Kamal Kant Kohli31 Aug 2023 9:30 AM ISTNetherlands: In frail elderly patients with atrial fibrillation, switching vitamin K antagonist (VKA) treatment to a non-vitamin K antagonist oral...
ESC 2023 Update: Trial demonstrates potential of acoramidis for transthyretin amyloid cardiomyopathy Dr. Kamal Kant Kohli31 Aug 2023 9:30 AM ISTAcoramidis improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with placebo, according to late breaking...
ESC 2023 Update: Anakinra is safe but did not increase the number of days free of myocarditis complications: ARAMIS trial Dr. Kamal Kant Kohli31 Aug 2023 9:00 AM ISTFrance: ARAMIS, the largest randomised controlled trial of acute myocarditis, revealed that a short course of anakinra did not increase the number of...
ESC 2023 Update: Dapagliflozin fails to improve diuretic efficiency in acute heart failure: DICTATE-AHF trial Dr. Kamal Kant Kohli31 Aug 2023 8:30 AM ISTUSA: Dapagliflozin can be safely started upon hospital admission to rapidly optimise guideline-directed medical therapy (GDMT) among hospitalized...
ESC 2023 Reaffirms CV Safety of Sulphonylureas Agents Prem Aggarwal30 Aug 2023 11:30 AM ISTThe European Society of Cardiology (ESC) has released new guidelines for managing cardiovascular disease among patients with diabetes, simplifying...
Inorganic nitrate reduces contrast-induced nephropathy among patients undergoing angiography Dr. Kamal Kant Kohli29 Aug 2023 8:00 PM ISTUK: Inorganic nitrate improves the safety of coronary angiography for patients at risk of renal injury, results from the NITRATE-CIN trial have...
ESC 2023 Update: 12 months of anticoagulation improves outcomes in cancer patients with minor blood clots Dr. Kamal Kant Kohli29 Aug 2023 11:45 AM ISTTwelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis ...
ESC 2023 Update: Traditional Chinese medicine qiliqiangxin shows meaningful clinical benefits in patients with HF Dr. Kamal Kant Kohli29 Aug 2023 9:45 AM ISTChina: A recent study has supported the role of the traditional Chinese medicine qiliqiangxin as an adjunct therapy for treating heart failure. The...
ESC 2023 Update: Presence of three or more unhealthy traits tied to earlier heart attack and stroke in middle-aged adults Dr. Kamal Kant Kohli29 Aug 2023 9:00 AM ISTSweden: People in their 40s and 50s having three or more unhealthy traits including high blood pressure, waist circumference, glucose, and cholesterol...
ESC 2023 Update: Extended P2Y12 inhibitor monotherapy benefits high-risk acute coronary syndrome patients Dr. Kamal Kant Kohli29 Aug 2023 8:45 AM IST Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischaemic events in acute ...
ESC Congress Guideline Update 2023: Important Highlights Isra Zaman28 Aug 2023 11:45 AM ISTImportant guideline updates have been released from the ESC congress 2023 held in Amsterdam between 25-28th August 2023. Here are important snippets...
